| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.41 | 2e-09 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.53 | 0.0003 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |